PharmaFeed » Firmagon http://www.pharmafeed.com Fri, 30 Jul 2010 11:55:26 +0000 http://wordpress.org/?v=2.9.1 en hourly 1 Ferring Approved to Commercialize Prostate Cancer Drug within EU http://www.pharmafeed.com/ferring-approved-to-commercialize-prostate-cancer-drug-within-eu http://www.pharmafeed.com/ferring-approved-to-commercialize-prostate-cancer-drug-within-eu#comments Mon, 23 Feb 2009 12:43:14 +0000 pharmafeed http://www.pharmafeed.com/?p=3298 Ferring Pharmaceuticals received authorization from the European Commission to market Firmagon, a prostate cancer drug. The treatment is a gonadotropin-releasing hormone receptor antagonist, indicated for patients with advanced, hormone-dependent prostate cancer. It is supplied as a powder to be reconstituted with sterile water for subcutaneous administration in the abdomen.

[ad]

The authorization follows degarelix’ FDA approval in December 2008.

In Phase III trials, Firmagnon reportedly reduced the levels of testosterone in more than 96% of patients within three days. Results were close to the immediate effect achieved with surgery, explains Ferring.

Source: GEN News

]]> http://www.pharmafeed.com/ferring-approved-to-commercialize-prostate-cancer-drug-within-eu/feed 0